U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659795) titled 'A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer' on June 15... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661199) titled 'Surgical Treatment of Adjacent Segment Stenosis' on May 29. Brief Summary: The goal of thi... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659535) titled 'Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the ... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661030) titled 'The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659652) titled 'Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More